|
Volumn 53, Issue , 2006, Pages 65-76
|
Oncolytic herpes simplex virus mutants exhibit enhanced replication in glioma cells evading temozolomide chemotherapy through deoxyribonucleic acid repair.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKYLATING AGENT;
DACARBAZINE;
DNA METHYLTRANSFERASE;
DRUG DERIVATIVE;
MGMT PROTEIN, HUMAN;
POLYDEOXYRIBONUCLEOTIDE SYNTHASE;
TEMOZOLOMIDE;
TUMOR SUPPRESSOR PROTEIN;
UNCLASSIFIED DRUG;
ANIMAL;
ARTICLE;
BRAIN TUMOR;
CULTURE TECHNIQUE;
GENETICS;
GLIOMA;
HERPES SIMPLEX VIRUS;
HUMAN;
MOUSE;
MULTIMODALITY CANCER THERAPY;
NUDE MOUSE;
ONCOLYTIC VIROTHERAPY;
PHYSIOLOGY;
TUMOR CELL LINE;
TUMOR SUPPRESSOR GENE;
ANIMALS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BRAIN NEOPLASMS;
CELL CULTURE TECHNIQUES;
CELL LINE, TUMOR;
COMBINED MODALITY THERAPY;
DACARBAZINE;
DNA MODIFICATION METHYLASES;
DNA REPAIR ENZYMES;
GENES, P53;
GLIOMA;
HUMANS;
MICE;
MICE, NUDE;
ONCOLYTIC VIROTHERAPY;
SIMPLEXVIRUS;
TUMOR SUPPRESSOR PROTEINS;
|
EID: 34248583495
PISSN: 00694827
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|